These results are in line with prior work, which reported the upregulation of AFAP1-AS1 in several cancers, such as pancreatic carcinoma [16], colon carcinoma, and lung carcinoma [17] and its correlation with adverse prognosis and malignant tumor traits. Here, AFAP1 is linked to lung carcinoma.